Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

15.55
Delayed Data
As of Jul 24
 -0.04 / -0.26%
Today’s Change
6.60
Today|||52-Week Range
18.24
+4.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization96.0K--156.00--
 
 
 
 
Operating ExpensesGross Income-96.0K0.00-156.000.00
 
 
 
General Expenses3.4M14.1M7.8M6.1M
 
 
 
 
 
Research And Development-103.0K7.8M5.5M4.4M
 
 
 
 
 
Total Operating Expenses3.5M14.1M7.8M6.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.5M-14.1M-7.8M-6.1M
 
 
 
 
 
Other Expenses91.0K0.0041.8K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.4M-14.0M-7.7M-6.0M
 
 
 
 
 
Net Income-3.4M-14.0M-7.7M-6.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.9M10.5M11.5M12.0M
 
 
 
 
 
Shares To Calculate EPS Diluted3.9M10.5M11.5M12.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.70-$1.34-$0.67-$0.50
 
 
 
 
 
EPS Diluted-$0.70-$1.34-$0.67-$0.50